Document is current

Article History

Received: 9 January 2026

Accepted: 16 February 2026

First Online: 5 March 2026

Declarations

:

: Individuals may consent to participate in a study, and consent to having their data published in a journal article.

: The study was approved by the Ethics Committee of Tianjin Union Medical Center (Approval No. 2022-B48) and conducted in accordance with the Declaration of Helsinki.1. Date of registration (needs to be before the Date of the First Patient): December 26, 2023. Trial registration was completed retrospectively due to administrative oversight during the COVID-19 pandemic. Initial patient enrollment began on January 9, 2019. All primary/secondary outcomes and statistical analysis plans were finalized prior to data analysis and database lock, consistent with ICMJE guidelines for post-hoc registration.2. Date of initial participant enrollment: January 9, 2019.3. Clinical trial identification number: ChiCTR2300079173.4. URL of the registration site:

: Authors make sure to seek consent from individuals to publish their data prior to submitting their paper to a journal.

: The authors declare no competing financial interests.